Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02406235 · ClinicalTrials.gov registry record
Evaluating a Novel Onco-genetic BRCA Testing Counselling Model Among Patients With Ovarian Cancer
A clinical trial, sponsored by AstraZeneca.
- Completed
- Registry status
- 710
- Enrollment target
NCT02406235 is a clinical trial that has completed, run by AstraZeneca. The registered enrollment target is 710 participants.
The verdict
NCT02406235 has completed, sponsored by AstraZeneca.
- COMPLETED
- Registry status
- 710 participants
- Enrollment target
Study Summary
The overall objective of this study is to assess turnaround time, pre-BRCA test onco-genetic counselling quality and satisfaction with a new onco-genetic BRCA testing model.
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 710 participants |
| Start Date | 2015-04-21 |
| Est. Completion | 2016-09-30 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT02406235
The ClinicalTrials.gov registry entry for NCT02406235 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 710 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is AstraZeneca, which has 1,285 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 0 interventions.
NCT02406235 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT02406235 about?
NCT02406235 is a clinical study titled "Evaluating a Novel Onco-genetic BRCA Testing Counselling Model Among Patients With Ovarian Cancer". The overall objective of this study is to assess turnaround time, pre-BRCA test onco-genetic counselling quality and satisfaction with a new onco-genetic BRCA testing model.
What is the current status of trial NCT02406235?
This trial is currently completed. The enrollment target is 710 participants. The study started on 2015-04-21. Estimated completion is 2016-09-30.
Who is sponsoring clinical trial NCT02406235?
This trial is sponsored by AstraZeneca, which has 1,285 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.